James D. Carlson

A leading early-phase contract research organization, PRACS has conducted more than 20,000 clinical pharmacology studies. With facilities across North America, PRACS offers flexible, quality clinical development services in a range of therapeutic areas. At PRACS they know their business and are committed to forward-thinking service. This is how they earned their reputation in the industry, as the go-to partner for early phase clinical pharmacology, bioanalytical, and scientific affairs services. PRACS offers nearly 30 years of concentrated and dedicated early clinical experience with specialized services specifically for Phase I/IIa.

Cetero Research is an industry leading contract research organization (CRO) in early phase research services. With more than 25 years of experience from its founding companies, Cetero has conducted more than 10,000 clinical pharmacology studies – more than any other CRO. Cetero’s proven track record allows the company to provide flexible and high quality drug development services, and its time-tested systems produce consistent and reliable data Cetero’s clients can trust. Cetero’s clinical research expertise consists of traditional early-stage, healthy-volunteer clinical pharmacology and bioavailability studies, as well as specialty Phase Ia/b trials in patients. Its bioanalytical services support clinical, preclinical drug and biomarker analysis for small and large molecules. In addition, Cetero owns and operates a full-scale central laboratory supporting Phase I-IV clinical trials in North and South America.

PRACS Institute Ltd. provides pre-clinical, clinical, bioanalytical and statistical research services. It offers services to the pharmaceutical, biotechnology and skin care industries. The company's services include in-house clinical laboratory, medical writing and expanding information technology support services. PRACS Institute was founded by James D. Carlson in 1983 and is headquartered in Fargo, ND.